Does TRASTUZUMAB Cause Dacryostenosis acquired? 71 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 71 reports of Dacryostenosis acquired have been filed in association with TRASTUZUMAB (Trazimera). This represents 0.2% of all adverse event reports for TRASTUZUMAB.
71
Reports of Dacryostenosis acquired with TRASTUZUMAB
0.2%
of all TRASTUZUMAB reports
3
Deaths
7
Hospitalizations
How Dangerous Is Dacryostenosis acquired From TRASTUZUMAB?
Of the 71 reports, 3 (4.2%) resulted in death, 7 (9.9%) required hospitalization, and 1 (1.4%) were considered life-threatening.
Is Dacryostenosis acquired Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for TRASTUZUMAB. However, 71 reports have been filed with the FAERS database.
What Other Side Effects Does TRASTUZUMAB Cause?
Diarrhoea (4,996)
Off label use (3,802)
Nausea (3,499)
Fatigue (3,417)
Myelosuppression (2,552)
Disease progression (2,449)
Death (2,378)
Vomiting (2,244)
Dyspnoea (2,010)
Pyrexia (1,886)
What Other Drugs Cause Dacryostenosis acquired?
DOCETAXEL (218)
DOCETAXEL\DOCETAXEL ANHYDROUS (84)
CYCLOPHOSPHAMIDE (62)
DUPILUMAB (57)
PERTUZUMAB (56)
CARBOPLATIN (49)
ADALIMUMAB (43)
NETARSUDIL (30)
LIFITEGRAST (26)
PACLITAXEL (24)
Which TRASTUZUMAB Alternatives Have Lower Dacryostenosis acquired Risk?
TRASTUZUMAB vs TRASTUZUMAB-ANNS
TRASTUZUMAB vs TRASTUZUMAB DERUXTECAN
TRASTUZUMAB vs TRASTUZUMAB-DKST
TRASTUZUMAB vs TRASTUZUMAB-DTTB
TRASTUZUMAB vs TRASTUZUMAB EMTANSINE